Stocks · Health care · Biological Products, (No Diagnostic Substances)

Kymera Therapeutics, Inc.

KYMR Clue Score27
United States Fiscal year ends December CIK 0001815442 Results filed 29 Oct 2026

What the insiders did No buying or selling

By person

14 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Baker Bros. Advisors LP entity
Director
—
—
—
7,955,916
$923.84M
+50.3%
Nello Mainolfi
Chief Executive Officer
—
—
—
666,568
$77.40M
+2.4%
Bruce Booth
Director
—
—
—
466,077
$54.12M
−81.5%
Bvf Partners L P/Il entity
Director
—
—
—
318,910
$37.03M
−80.5%
Bruce N. Jacobs
Chief Financial Officer
—
—
—
244,883
$28.44M
+44.2%
Jared Gollob
Chief Medical Officer
—
—
—
117,134
$13.60M
+22.3%
Ellen Chiniara
Chief Legal Officer
—
—
—
80,085
$9.30M
+38.2%
Brian Adams
Chief Legal Officer
—
—
—
50,254
$5.84M
—
Noah Goodman
Chief Business Officer
—
—
—
47,179
$5.48M
+10,282%
Jeremy G Chadwick
Chief Operating Officer
—
—
—
44,018
$5.11M
−4.6%
Terence Rooney
Chief Medical Officer
—
—
—
38,000
$4.41M
—
Pamela Esposito
Director
—
—
—
1,000
$116.12K
—
Jeffrey W. Albers
Director
—
—
—
0
$0.00
—
Elena Ridloff
Director
—
—
—
0
$0.00
—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.